Zhang Kevin, Misra Avika, Kim Patrick J, Moghadas Seyed M, Langley Joanne M, Smieja Marek
Faculty of Medicine, University of Toronto, Toronto, ON.
Faculty of Medicine, University of Ottawa, Ottawa, ON.
Can Commun Dis Rep. 2021 May 7;47(4):202-209. doi: 10.14745/ccdr.v47i04a04.
Public health measures, such as physical distancing and closure of schools and non-essential services, were rapidly implemented in Canada to interrupt the spread of the coronavirus disease 2019 (COVID-19). We sought to investigate the impact of mitigation measures during the spring wave of COVID-19 on the incidence of other laboratory-confirmed respiratory viruses in Hamilton, Ontario.
All nasopharyngeal swab specimens (n=57,503) submitted for routine respiratory virus testing at a regional laboratory serving all acute-care hospitals in Hamilton between January 2010 and June 2020 were reviewed. Testing for influenza A and B, respiratory syncytial virus, human metapneumovirus, parainfluenza I-III, adenovirus, and rhinovirus/enterovirus was done routinely using a laboratory-developed polymerase chain reaction multiplex respiratory viral panel. A Bayesian linear regression model was used to determine the trend of positivity rates of all influenza samples for the first 26 weeks of each year from 2010 to 2019. The mean positivity rate of Bayesian inference was compared with the weekly reported positivity rate of influenza samples in 2020.
The positivity rate of influenza in 2020 diminished sharply following the population-wide implementation of COVID-19 interventions. Weeks 12-26 reported 0% positivity for influenza, with the exception of 0.1% reported in week 13.
Public health measures implemented during the COVID-19 pandemic were associated with a reduced incidence of other respiratory viruses and should be considered to mitigate severe seasonal influenza and other respiratory virus pandemics.
加拿大迅速实施了公共卫生措施,如保持身体距离以及关闭学校和非必要服务场所,以阻断2019冠状病毒病(COVID-19)的传播。我们试图调查安大略省汉密尔顿市在COVID-19春季疫情期间缓解措施对其他实验室确诊呼吸道病毒发病率的影响。
回顾了2010年1月至2020年6月期间在为汉密尔顿市所有急症医院服务的一家区域实验室提交的用于常规呼吸道病毒检测的所有鼻咽拭子标本(n = 57,503)。使用实验室开发的聚合酶链反应多重呼吸道病毒检测板对甲型和乙型流感病毒、呼吸道合胞病毒、人偏肺病毒、副流感病毒I - III型、腺病毒和鼻病毒/肠道病毒进行常规检测。采用贝叶斯线性回归模型确定2010年至2019年每年前26周所有流感样本阳性率的趋势。将贝叶斯推断的平均阳性率与2020年每周报告的流感样本阳性率进行比较。
在全市范围内实施COVID-19干预措施后,2020年流感的阳性率急剧下降。第12 - 26周报告流感阳性率为0%,第13周除外,报告阳性率为0.1%。
COVID-19大流行期间实施的公共卫生措施与其他呼吸道病毒发病率降低有关,应考虑将其用于缓解严重的季节性流感和其他呼吸道病毒大流行。